Ετικέτες

Τρίτη 19 Δεκεμβρίου 2017

Scholar : ΣΤΟΜΑΤΙΤΙΣ - νέα αποτελέσματ

[HTML] A Follow-up Study of Clinical Characteristics of Recurrent Aphthous Stomatitis Patients Treated with Herbal Medicine

N Ha, J Lee, J Lee, S Nam, W Ko, M Hwang, J Kim - The Journal of Internal Korean …, 2017
Objectives The purpose of this study was to report the long-term efficacy of herbal medicine
for treatment of patients with recurrent aphthous stomatitis (RAS). Methods We reviewed the
clinical records of 17 patients with RAS who visited the Oral Diseases Clinic of Kyung Hee
Google+ Facebook Twitter

Polyvalent immunoglobulins with vitamin D3 and vitamin B12 in the treatment of Sjogren's syndrome in a vegetarian with stomatitis, glossodynia, xerostomia, and …

C Cuny, B Vaerst, J Gabrielpillai, A Tahtali, S Balster… - International journal of …, 2017
BACKGROUND: Sjogren's syndrome, involving sicca symptoms with xerostomia, stomatitis,
and considerable pain is a difficult-to-treat autoimmune disease where the treatment options
are limited and, as in the case of methotrexate, have a low therapeutic index. CASE
Google+ Facebook Twitter

[PDF] Treatment of Recurrent Aphthous Stomatitis by 100% Topical Pumpkin Seed Oil

KE Sharquie, AA Noaimi, TM Latif - 2017
Abstract Background: Recurrent aphthous stomatitis (RAS) is a major oral health problem,
where its etiopathogenesis is not well understood. Accordingly, its therapy whether topical or
systemic can induce clearance, but the relapse rate is high. Objective: To use 100% topical
Google+ Facebook Twitter

Prevalence of Periodontal Diseases in Children with Herpetic Stomatitis in City Tashkent

A Ibrokhimov - World Academy of Science, Engineering and …, 2017
Abstract: Update of preventive medicine has exacerbated the problem of cause-and-effect
relationship between the presence of herpetic stomatitis (HS) and periodontal disease.
Comprehensive survey of children with herpetic stomatitis, according to WHO equirements,
Google+ Facebook Twitter

Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial

TE Witzig, K Tobinai, L Rigacci, T Ikeda, A Vanazzi… - Annals of Oncology, 2017
… Common grade 3/4 AEs with everolimus were neutropenia, stomatitis, and decreased CD4
lymphocytes. Page 4 … (24%, everolimus; 15%, placebo). The three most commonly reported AEs
were stomatitis, diarrhea, and neutropenia with everolimus and neutropenia, fatigue, and …
Google+ Facebook Twitter

[PDF] Efecto Inhibidor de la Miel De Bórax sobre el crecimiento de Candida Albicans, aislada de pacientes con lesiones de Estomatitis Subprotesica

L Pabón, M Lugo, L Bustillos, AG Betancourt, EJ Salas - Acta Bioclínica, 2017
… albicans, ISOLATED OF PATIENTS WITH LESIONS OF SUBPROTESIC STOMATITIS. ABSTRACT
In the oral cavity, several pathologies are present, one of the most frequent is the subperitoneal
stomatitis (ESP) of multifactorial etiology that affects with high prevalence of …
Google+ Facebook Twitter

[HTML] The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon …

CJ Yang, MJ Tsai, JY Hung, MH Lee, YM Tsai, YC Tsai… - BMC Pharmacology and …, 2017
Skip to content Advertisement …
Google+ Facebook Twitter

Vanadium: A Panacea for Resistance to Oncolytic Immunotherapy?

D Zamarin - Molecular Therapy, 2017
… 13. Given the latter, the authors explored the interaction between vanadate compounds and OVs,
using vesicular stomatitis virus (VSV) as a model … Interference of CD40L-mediated tumor
immunotherapy by oncolytic vesicular stomatitis virus. Hum. Gene Ther., 21 (2010), pp …
Google+ Facebook Twitter

GPATCH3 调控 RIG-I 样受体介导的天然免疫反应的分子机制

聂映 - 2017
… 降低细胞中GPATCH3的表达能够增强SeV诱导的IFNB1、IFNB1下游基因ISGs以及炎症基因的转录,
但对DNA病毒HCMV及双链DNA(dsDNA)HSV-120诱导的IFNB1的转录没有影响。与此一致,降低
GPATCH3的表达能够显著地抑制SeV和VSV(Vesicular stomatitis virus)两种RNA …
Google+ Facebook Twitter

[PDF] Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors

R Salazar, R Garcia‐Carbonero, SK Libutti… - The Oncologist, 2017
… The most commonly reported all-grade adverse events (>50% of patients regardless of study
treatment relationship) with BEZ235 were diarrhea (90.3%), stomatitis (74.2%), and nausea
(54.8%). Conclusion … Stomatitis 23 (74.2) 4 (12.9) 20 (64.5) 2 (6.5) …
Google+ Facebook Twitter


Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google

Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου


Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου